CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation

Jeong-Hwa Kwon, Byung-Kwan Jeong, Yong Sik Yoon, Chang Sik Yu, Jihun Kim

JPTM. 2018;52(3):157-163. Published online 2018 March 29 DOI: https://doi.org/10.4132/jptm.2018.03.28

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation

Jeong-Hwa Kwon, Byung-Kwan Jeong, Yong Sik Yoon, Chang Sik Yu, Jihun Kim

Journal of Pathology and Translational Medicine. 2018;52(3):157-163

Link1

Link2 Link3

BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma

Kajsa Affolter, Wade Samowitz, Sheryl Tripp, Mary P. Bronner

Genes, Chromosomes and Cancer. 2013;52(8):748-752

Link1 Link2

Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review

Katerina Dvorak, Amanda Higgins, John Palting, Michael Cohen, Patrick Brunhoeber

Pathology & Oncology Research. 2017;25(1):349-359

Link1 Link2

Link3

Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma

Cheryl A Adackapara, Lynette M Sholl, Justine A Barletta, Jason L Hornick

Histopathology. 2013;63(2):187-193

Link1 Link2

BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer

David Capper, Anita Voigt, Gergana Bozukova, Aysel Ahadova, Philipp Kickingereder, Andreas von Deimling, Magnus von Knebel Doeberitz, Matthias Kloor

International Journal of Cancer. 2013;133(7):1624-1630

Link1 Link2

Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis

Kyle G. Parker, Michael G. White, Nicole A. Cipriani

Head and Neck Pathology. 2020;14(4):1067-1079

Link1

Link2 Link3

BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas

Mahtab Farzin, Christopher W. Toon, Adele Clarkson, Loretta Sioson, Anthony J. Gill

Pathology. 2014;46(1):79-80

Link1 Link2

Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1

Hui Liu, Zhongwu Li, Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo, Weicheng Xue

Pathology International. 2014;n/a-n/a

Link1 Link2

Validation of the VE1 immunostain for theBRAFV600E mutation in melanoma

Michelle V. Pearlstein, Daniel C. Zedek, David W. Ollila, Amanda Treece, Margaret L. Gulley, Pamela A. Groben, Nancy E. Thomas

Journal of Cutaneous Pathology. 2014;41(9):724-732

Link1

VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation

Jan Sperveslage, Midea Gierke, David Capper, Jürgen Honegger, Bence Sipos, Rudi Beschorner, Jens Schittenhelm

Acta Neuropathologica. 2013;125(6):911-912

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.